Hem › Cystisk fibros › Kansas › Kansas City
Kliniska studier för Cystisk fibros i Kansas City, KS
13 studier för Cystisk fibros söker deltagare vid platser i och runt Kansas City (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
Phase 2 Study to Assess the Safety and Efficacy of ANG003
RekryterarFas 2
- University of Kansas Medical Center, Kansas City
Sinus Disease in Young Children With Cystic Fibrosis
RekryterarObservationsstudie
- University of Kansas Medical Center, Kansas City
Study to Evaluate Biological & Clinical Effects of Significantly Corrected CFTR Function in Infants & Young Children
RekryterarObservationsstudie
- University of Kansas Medical Center, Kansas City
Standardizing Treatments for Pulmonary Exacerbations - Aminoglycoside Study
RekryterarFas 4
- University of Kansas Medical Center, Kansas City
4D-710 in Adult Patients With Cystic Fibrosis
RekryterarFas 2
- University of Kansas Medical Center, Kansas City
Evaluation of Ventilation Defects Downstream of Mucus Plugs in Patients With Muco-Obstructive Lung Disease
RekryterarObservationsstudie
- University of Kansas Medical Center, Kansas City
Hyperpolarized 129Xe MR Imaging of Lung Function in Healthy Volunteers and Subjects With Pulmonary Disease
RekryterarFas 1Friska volontärer välkomna
- University of Kansas Medical Center, Kansas City
Metformin for People With CFRD on CFTR Modulator Therapy to Improve Ion Channel Function
RekryterarFas 2
- University of Kansas Medical Center, Kansas City
Health Outcomes of Parents With Cystic Fibrosis-Aim 2
RekryterarObservationsstudie
- University of Kansas Medical Center, Kansas City
Restarting Triple Therapy With Robust Monitoring for Adverse Events (RETRIAL)
RekryterarObservationsstudie
- Kansas University Medical Center, Kansas City
A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators
RekryterarObservationsstudie
- University of Kansas Medical Center, Kansas City
Targeting Inflammation With Losartan to Improve Response to Modulator Therapy in Cystic Fibrosis.
RekryterarFas 2
- University of Kansas Medical Center, Kansas City
A Phase 1/2 Trial of SP-101 for the Treatment of Cystic Fibrosis (CF)
RekryterarFas 1/2
- University of Kansas Medical Center, Kansas City
Cystisk fibros-studier i andra städer
- Boston, MA17 studier
- Birmingham, AL16 studier
- Philadelphia, PA15 studier
- Seattle, WA12 studier
- Baltimore, MD12 studier
- Denver, CO11 studier
- Dallas, TX11 studier
- Pittsburgh, PA11 studier
- Cincinnati, OH10 studier
- Los Angeles, CA9 studier
- Aurora, CO9 studier
- Minneapolis, MN8 studier
Andra studier i Kansas City
- Hjärt-kärlsjukdom14 studier
- Hjärtsvikt13 studier
- Övervikt13 studier
- Interstitiella lungsjukdomar13 studier
- Bröstcancer12 studier
- Blåscancer12 studier
- Akut myeloid leukemi12 studier
- Prostatacancer12 studier
- Icke-småcellig lungcancer11 studier
- Lungcancer11 studier
- KOL9 studier
- Astma8 studier
Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.